MOWOOT (usMima SL) is the medtech company that emerged out of Moebio EU Stanford Biodesign program by Biocat and that, in close collaboration with Institut Guttmann (Barcelona), developed Mowoot, the first intermittent colonic exoperistalsis device, a natural solution for chronic constipation.

Mowoot offers a CE certified (medical device class IIa), IP protected, clinically validated and award-winning technology: the first automated exoperistalsis device on the market handling a large unmet need for patients with chronic constipation.

Today, Mowoot is already commercialized in Spain, UK, the Netherlands Denmark and Germany, where we expect to get into public health reimbursement soon.